Human Papillomavirus (HPV) Vaccines

Genital human papillomavirus (HPV) is the most common sexually transmitted virus in the U.S. Vaccine Can is given starting at 9 years of age. HPV is also associated with several less common types of cancer in both men and women. It can also cause genital warts and warts in the upper respiratory tract. More than 50% of sexually active men and women are infected with HPV at some time in their lives.

  • Indication and Usage – Dosage and Administration
  • Dosage Forms, Strengths and Contraindications
  • Adverse Reactions and Drug Interactions
  • HPV Vaccination
  • Contraindications and precautions

Related Conference of Human Papillomavirus (HPV) Vaccines

May 30-31, 2024

World congress on Immunology and Virology Diseases

Vienna, Austria
August 01-02, 2024

44th Global Summit and Expo on Vaccines & Immunology

Montreal, Canada
September 09-10, 2024

4th International Conference on Vaccine Research

Madrid, Spain
September 09-10, 2024

7th International Conference on Vaccines and Immunology

Madrid, Spain
November 28-29, 2024

6th World Congress on Vaccine and Immunology

Paris, France

Human Papillomavirus (HPV) Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in